D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum

We demonstrate a heteromeric D1-D2 dopamine receptor signaling complex in brain that is coupled to Gq/11 and requires agonist binding to both receptors for G protein activation and intracellular calcium release. The D1 agonist SKF83959 was identified as a specific agonist for the heteromer that acti...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 104; no. 2; pp. 654 - 659
Main Authors Rashid, Asim J, So, Christopher H, Kong, Michael M.C, Furtak, Teresa, El-Ghundi, Mufida, Cheng, Regina, O'Dowd, Brian F, George, Susan R
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 09.01.2007
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We demonstrate a heteromeric D1-D2 dopamine receptor signaling complex in brain that is coupled to Gq/11 and requires agonist binding to both receptors for G protein activation and intracellular calcium release. The D1 agonist SKF83959 was identified as a specific agonist for the heteromer that activated Gq/11 by functioning as a full agonist for the D1 receptor and a high-affinity partial agonist for a pertussis toxin-resistant D2 receptor within the complex. We provide evidence that the D1-D2 signaling complex can be more readily detected in mice that are 8 months in age compared with animals that are 3 months old, suggesting that calcium signaling through the D1-D2 dopamine receptor complex is relevant for function in the postadolescent brain. Activation of Gq/11 through the heteromer increases levels of calcium/calmodulin-dependent protein kinase IIα in the nucleus accumbens, unlike activation of Gs/olf-coupled D1 receptors, indicating a mechanism by which D1-D2 dopamine receptor complexes may contribute to synaptic plasticity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by Robert J. Lefkowitz, Duke University Medical Center, Durham, NC, and approved November 9, 2006
Author contributions: B.F.O. and S.R.G. contributed equally to this paper; A.J.R., C.H.S., M.M.C.K., and S.R.G. designed research; A.J.R., C.H.S., M.M.C.K., T.F., and R.C. performed research; M.E.-G. contributed new reagents/analytic tools; A.J.R., C.H.S., M.M.C.K., T.F., B.F.O., and S.R.G. analyzed data; and A.J.R., B.F.O., and S.R.G. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0604049104